Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.
The recent approval by the US Food and Drug Administration (FDA) of the Absorb GT1 bioresorbable vascular scaffold (BVS) system (Abbott Vascular) got me thinking about a modern-day medical problem: ...
WASHINGTON, DC—Coronary stent infections are highly fatal and represent an understudied complication following PCI, a new analysis highlights. “Several important questions about coronary stent ...
XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Has the Potential to Reduce Overall Procedural Costs Very Long Lesions Most Often Seen in ...
While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers from the Duke Clinical Research Institute have found ...
Drug-eluting coronary-artery stents have been shown to decrease restenosis and therefore the likelihood that additional procedures will be required after percutaneous coronary intervention (PCI). We ...
A new report published Tuesday found over one in five coronary stents placed between 2019 and 2021 were unnecessary, costing Medicare $800 million a year and putting patients at risk of complications ...
The world's first drug-eluting bioresorbable plastic vascular scaffold (BVS) is now widely available across Europe and parts of Asia Pacific and Latin America. The Absorb BVS from Abbott (Abbott Park, ...
DUBLIN--(BUSINESS WIRE)--The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market was valued at ...
Drug-eluting stents (DES) have revolutionized the practice of interventional cardiology over the past decade. Although their efficacy has never been called into question, concerns have been raised ...
A stent is a small mesh tube inserted into an artery that has been narrowed by plaque build-up. In the US, nearly two million stents are implanted every year, and they can be life-saving during a ...
Over $8 billion worth of coronary stents will be sold annually by 2025, according to a new research report by Global Market Insights, Inc. The increase over the years will be created by an increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results